ASHLEY SENSS: Open Payments
NPI 1013519420 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 51 payments from 14 companies in 2025. Trend: 2023 $549 · 2024 $912 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $379 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Incyte Corporation | 4 | $98 |
| PFIZER INC. | 3 | $85 |
| Janssen Biotech, Inc. | 3 | $75 |
| Arcutis Biotherapeutics, Inc. | 2 | $46 |
| Organon LLC | 3 | $41 |
| Amgen Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
Products named: RINVOQ, SKYRIZI, OPZELURA, CIBINQO, DUPIXENT, TREMFYA, Zoryve, OTEZLA.
Industry payments across PA — which companies pay providers there.
